Indeed, exogenous administration of BMP4 to immunocompromised mice with tumors, which arose from colon CSCs, increased the antitumor effects of 5-fluorouracil and oxaliplatin, confirming that BMP4 might be developed as a therapeutic agent against cancer stem cells in advanced colorectal tumors [24]. Here, BMP4 is linked to colorectal neoplasm.